Talcum Powder Lawsuit Leads for Law Firms — Since 2009

Talcum Powder Lawsuit Leads, Screened for the Litigation Happening Now

Exclusive, ovarian-cancer talc claimants — qualified to current MDL 2738 criteria, LexisNexis verified, and delivered signed-retainer-ready. With the bankruptcy shield gone and the first federal bellwether on the 2026 calendar, the firms building docket are sourcing tightly-screened claimants now. If a lead doesn't match your criteria, we replace it at no cost.

Get Your Talc Leads Quote Call (800) 889-1679

68K+Pending in MDL 2738

60K+Leads Delivered

3–5Days to First Lead

15+Years Experience

Why Talc, Why Now

The Talc Window Is Open —
But the Rules Just Changed

Talcum powder is the single largest active multidistrict litigation in the country. Two structural shifts make this an unusual moment to build a docket: the bankruptcy firewall is gone, and the fight has moved to the science. Here is how the docket arrived where it is — and what each step means for the claimants you acquire.

2016 — Present

MDL 2738 Consolidated in New Jersey

Federal ovarian-cancer talc claims are coordinated as In re: Johnson & Johnson Talcum Powder Products, MDL No. 2738, before Judge Michael A. Shipp in the District of New Jersey — roughly 68,029 pending actions as of June 1, 2026, and 90,000+ talc claims nationwide once state court is counted.

2021 – 2025

The "Texas Two-Step" Fails — Three Times

J&J attempted to contain talc liability through subsidiary bankruptcies on three separate occasions. All three were rejected; the final multibillion-dollar plan through Red River Talc was thrown out in 2025, and J&J declined to appeal. There is no Chapter 11 firewall left.

Late 2025 – 2026

Record Verdicts as Cases Reach Juries

With every case now on a live path to trial, juries have returned a series of major awards — including a $1.5 billion single-plaintiff mesothelioma verdict in Baltimore. The record is genuinely split, with defense verdicts on the ovarian theory as well.

2026 — Active

The Fight Moves to Causation

Expert and Daubert / Rule 702 challenges are now the center of gravity, with J&J pressing hard on whether causation testimony is admissible. The practical takeaway: documentation and criteria precision now decide what a talc claim is worth.

Later in 2026

First Federal Bellwether on the Calendar

The Judkins bellwether — the first federal talc trial — is on track for later in 2026. A plaintiff verdict in the largest active MDL would reverberate across the entire docket and reshape settlement posture.

Talcum powder litigation — MDL 2738 proceedings

What It Means for Buyers

This Is No Longer a Tort Where Volume Wins

Verdicts up, competition softerAdvertising competition has eased even as awards hit records — a comparatively favorable acquisition window.

Thin leads lose valueAs the causation fight intensifies, a loosely-screened talc lead is worth less than it was a year ago.

Documented claims winA confirmed ovarian diagnosis with a multi-year use history and clean timeline is worth more — and harder to source.

The clock is runningStatutes of limitation vary by state. Firms that build qualified inventory now are positioned ahead of the wave.

Litigation status summarized from public court records and the JPML statistics report dated June 1, 2026. Case counts and schedules change frequently; figures are a snapshot. All health claims described are allegations being litigated, not established findings.

The Verdict Pipeline

Juries Have Repeatedly Valued Talc Cases in the Millions

A sample of recent talc awards. They illustrate jury appetite — not a promise of outcome. The record is split, and we show a defense result too, because honest economics start with the full picture.

$1.5B

Dec 2025 · Baltimore

Largest single-plaintiff talc verdict on record — a peritoneal mesothelioma case tied to decades of product use.

$40M

Dec 2025 · California

Awarded to two women in a state-court ovarian cancer bellwether trial against J&J.

$65.5M

Dec 2025 · Minnesota

Returned in a talc case after the jury found a failure to warn about potential asbestos contamination.

Defense

June 2026 · California

J&J won a state ovarian bellwether — proof causation is contested and why claim quality is decisive.

Why we show the defense verdict. The ovarian-cancer causation theory is genuinely contested, and the science is being fought in real time. That is precisely why a well-documented claimant — confirmed diagnosis, long use history, clean timeline — is worth more to your docket than raw volume. We screen for the facts that survive scrutiny.

How We Qualify a Talc Lead

Claimants Screened to the Criteria That Actually Hold Up

We don't hand you a name and a phone number. Every talc claimant passes through the qualification gates that determine whether a case holds up in MDL 2738 or a state coordinated proceeding. You set the filters; we tailor the intake script to your firm's admission criteria.

Diagnosis Match

A confirmed ovarian cancer diagnosis (the MDL's current scope) — or, for separate mesothelioma campaigns, a confirmed mesothelioma diagnosis. We don't blend the two.

Product-Use History

Regular, long-term perineal use of J&J Baby Powder, Shower-to-Shower, or comparable talc products — with the use timeline captured at intake.

Causation Timeline

Diagnosis date relative to the use period, documented so the file reflects a coherent, defensible timeline rather than a bare assertion.

Statute-of-Limitations Screen

Flagged against the claimant's state before delivery, so cases land inside the window where your firm is positioned to file.

No Prior Representation

Verified the claimant is not already retained elsewhere — the single most common reason an exclusive lead turns out to be worthless.

Identity Verification

LexisNexis confirmation of SSN, address, and date of birth, plus Lead Insight fraud screening, before a claimant ever reaches your CRM.

Federal · MDL 2738

Ovarian Cancer Campaign

The federal MDL is currently ovarian-cancer only. We acquire and screen women with a confirmed ovarian diagnosis and a documented, multi-year perineal use history — the core of the largest active mass tort in the country.

State Court · Separate Track

Mesothelioma Campaign

Mesothelioma claims are litigated separately, largely in state court, and run as their own campaign with their own criteria. We never mix them into your ovarian docket — they're routed to the right part of your firm.

Set Your Criteria & Get Pricing

Talcum powder lead acquisition and case economics for plaintiff firms

The Economics

Exclusive, Because Shared Talc Leads Don't Pencil Out

Shared talc leads look cheap until you run the math. Across mass tort, shared inquiries convert to signed retainers in the low single digits because three other firms are calling the same claimant. Your true number is never cost-per-lead — it's cost per signed retainer, and that's where exclusivity wins.

Every talc claimant we deliver is 100% exclusive to your firm — captured, verified, and routed to your CRM, never resold. We'll model your expected cost-per-signed-case against your criteria before you commit a dollar.

See Your Talc Numbers Call Us Now

~$940

Cost / Signed Retainer

Procurement-grade midpoint benchmark for talc.

$40–$60

Cost / Lead

Competitive band for the talc vertical.

15–20%+

Exclusive Conversion

Vs. 2–5% on shared leads chased by multiple firms.

$800–$3.5K

Mass-Tort Signed Case

Broad range by channel and intake discipline.

Competition down, verdicts up

The Buy-Window

Talc advertising competition has softened even as awards hit records — a comparatively favorable moment in a tort where juries have repeatedly valued cases in the millions.

Figures are third-party industry benchmarks (talc and closest comparables, 2026), shown for context — not a quoted Injury Case Claims price. Your campaign is quoted against your specific criteria, states, and delivery format.

Get Started

Get Your Talc Leads
Quote Today

If your firm is building a talcum powder, mass tort MDL, or Personal Injury docket, give us the opportunity to earn your business.

We promise the best quality with the industry's best return policy. No other company offers investment protection like we do.

✓ Exclusive Ovarian-Cancer & Mesothelioma Claimants

✓ Qualified to MDL 2738 / State-Court Criteria

✓ LexisNexis Verified · TCPA / Jornaya / TrustedForm

✓ Live Transfer, API, or Signed-Retainer Packets

✓ Free Replacement if a Lead Doesn't Match Your Criteria

✓ 60,000+ Leads Delivered Since 2009

10:11

Recent Leads

Recent Leads Appointments Notifications

Real-Time Leads

Instant updates so you never miss an opportunity.

Qualified Cases

Every lead is pre-screened and ready to convert.

Maximum Results

Our technology connects you with high-value cases.

Secure & Reliable

Your data and leads are always protected.

Experience Matters

EST. 2009 ★★★★★

First Name

Last Name

Law Firm Name

Email Address

Phone Number

Talc Lead Type of Interest

Tell us about your needs

By submitting, you consent to be contacted by InjuryCaseClaims.com regarding your inquiry. This does not constitute a binding agreement. All information is handled securely and confidentially.

FAQ

Frequently Asked Questions About Talc Leads

Everything your firm needs to know before launching your first talcum powder campaign with Injury Case Claims.

Yes. MDL 2738 remains active and growing — it added thousands of cases over the past year and stood near 68,000 pending actions as of June 1, 2026. Intake is open, but MDL posture can shift, so firms generally benefit from building qualified inventory while the window is open. We can scale your campaign up or down as the litigation moves.

For the federal MDL (currently ovarian-cancer only): a confirmed ovarian cancer diagnosis, documented regular long-term perineal use of talc products, a diagnosis timeline consistent with that use, a clean statute-of-limitations posture for the claimant's state, and no existing legal representation. Mesothelioma claims run as a separate campaign because they're litigated separately, largely in state court.

Yes. Every talc claimant is delivered to one firm only and never resold. Shared talc leads convert poorly because multiple firms chase the same person; exclusivity is what makes the cost-per-signed-case work.

It depends on your criteria, target states, exclusivity, and delivery format. Industry benchmarks put talc cost-per-lead in roughly the $40–$60 range and cost per signed retainer near $940, but your real number is cost-per-signed-case, which we'll model with you. Request talc pricing and we'll quote against your exact filters.

J&J has moved to challenge expert and causation evidence, so the admissibility battle is live. Practically, it raises the value of well-documented, tightly-qualified claims and lowers the value of thin ones. It's a reason to be more selective about lead quality, not a reason to sit out — and our screening is built for exactly that.

Both. You can take live-transferred or API-delivered leads and run your own intake, or receive complete signed-retainer packets (retainer, HIPAA, HITECH, and questionnaire) ready for your file.

Talcum Powder Lawsuit Leads, Screened for the Litigation Happening Now